Cargando…

Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics

Detalles Bibliográficos
Autor principal:	Maron, Bradley A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427395/ https://www.ncbi.nlm.nih.gov/pubmed/32453600 http://dx.doi.org/10.1164/rccm.202004-1411ED

Ejemplares similares

TORward a Molecular Convergence Point in Pulmonary Arterial Hypertension With mTOR
por: Maron, Bradley A., et al.
Publicado: (2018)

Pulmonary arterial hypertension: Cellular and molecular changes in the lung
por: Maron, Bradley A.
Publicado: (2020)

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
por: Leopold, Jane A., et al.
Publicado: (2016)

Introducing the Pulmonary Hypertension Thematic Series
por: Maron, Bradley A.
Publicado: (2023)

Pulmonary arterial hypertension: Rationale for using multiple vs. single drug therapy
por: Maron, Bradley A.
Publicado: (2020)

Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction. Where to Draw the Line
por: Simon, Marc A., et al.
Publicado: (2019)

Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure
por: Oliveira, Rudolf K. F., et al.
Publicado: (2017)

Chronic thromboembolic pulmonary hypertension: the evolving treatment landscape
por: Kim, Nick H., et al.
Publicado: (2015)

What is pulmonary arterial hypertension?
por: Rich, Stuart
Publicado: (2012)

The revolution of pulmonary arterial hypertension
por: Harari, Sergio
Publicado: (2016)

Pulmonary Arterial Hypertension: A Deeper Evaluation of Genetic Risk in the -Omics Era
por: Machado, Rajiv D., et al.
Publicado: (2021)

New Tricks for an Old Drug: Prostacyclins and Right Ventricular Contractility in Pulmonary Arterial Hypertension
por: Wertheim, Bradley M.
Publicado: (2022)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Pulmonary Arterial Hypertension in Genetic and Comorbid Settings: A Step Forward for Precision Medicine
por: Madonna, Rosalinda
Publicado: (2022)

Clarifying the Effect of Sleep Deprivation on the Respiratory Muscles
por: Laghi, Franco, et al.
Publicado: (2020)

Clarifying "never events and introducing "always events"
por: Lembitz, Alan, et al.
Publicado: (2009)

VITAMIN D AND ASTHMA: A RELATIONSHIP TO BE CLARIFIED
por: Wandalsen, Gustavo Falbo, et al.
Publicado: (2018)

The evolving landscape of combination therapy for pulmonary arterial hypertension
por: Griffin, Matthew, et al.
Publicado: (2016)

The success of pulmonary hypertension treatment: improved cardiac function by reducing the arterial load
por: Vonk-Noordegraaf, Anton, et al.
Publicado: (2018)

A Plot TWIST in Pulmonary Arterial Hypertension
por: Misner, Kevin, et al.
Publicado: (2020)

Deconstructing the Melting Pot in Pulmonary Arterial Hypertension
por: Austin, Eric D., et al.
Publicado: (2020)

New Therapeutic Target for Pulmonary Arterial Hypertension
por: Yoon, Kyung Lim
Publicado: (2018)

Iron deficiency in pulmonary arterial hypertension: perspectives
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

New horizons in pulmonary arterial hypertension management
por: McLaughlin, Vallerie, et al.
Publicado: (2014)

The Molecular Genetics and Cellular Mechanisms Underlying Pulmonary Arterial Hypertension
por: Machado, Rajiv D.
Publicado: (2012)

Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial Hypertension
por: Fazal, Shahood, et al.
Publicado: (2021)

Can We Clarify the Causative Gene/Variants Underlying Familial Hypercholesterolemia and Improve Genetic Diagnosis Rate?
por: Hori, Mika
Publicado: (2022)

Isolating pulmonary microvascular endothelial cells ex vivo: Implications for pulmonary arterial hypertension, and a caution on the use of commercial biomaterials
por: Wertheim, Bradley M., et al.
Publicado: (2019)

Clarifying WHO’s position on the FRAX® tool for fracture prediction
por: Ford, Nathan, et al.
Publicado: (2016)

Sirtuin 3 and Uncouplin Protein 2, the Missing Link Between Genetics, Metabolism, and Pulmonary Arterial Hypertension
por: Lajoie, Annie C., et al.
Publicado: (2021)

Clarifying the anatomy of the fifth arch artery
por: Gupta, Saurabh Kumar, et al.
Publicado: (2016)

Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension
por: Gillmeyer, Kari R., et al.
Publicado: (2022)

Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer
por: Maron, Bradley A.
Publicado: (2023)

Quality of life in pulmonary arterial hypertension
por: Post, M.C., et al.
Publicado: (2015)

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019)

Pulmonary arterial hypertension in adults with atrial septal defect
por: Toyono, Manatomo
Publicado: (2012)

A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension
por: Grinnan, Daniel, et al.
Publicado: (2019)

Pulmonary arterial hypertension in scleroderma: care gaps in screening
por: Pope, Janet E.
Publicado: (2017)

Pulmonary arterial hypertension registries: past, present and into the future
por: Weatherald, Jason, et al.
Publicado: (2019)

Role of Ion Channels in the Development of Pulmonary Arterial Hypertension
por: Antigny, Fabrice
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u6vaptrp9l11u9gjbbilvdlcmu